Research Analysts Set Expectations for Surmodics Q3 Earnings
Surmodics, Inc. (NASDAQ:SRDX – Free Report) – Analysts at Zacks Research decreased their Q3 2025 EPS estimates for Surmodics in a research note issued to investors on Wednesday, February 19th. Zacks Research analyst D. Dey now expects that the company will post earnings of $0.08 per share for the quarter, down from their previous forecast […]
